Elevation of CRABP-I in the Cerebrospinal Fluid of Patients with Moyamoya Disease

Stroke

Volumn 34, Issue 12, 2003, Pages 2835-2841

  Kim, Seung Ki ^a   Yoo, Jong Il ^b   Cho, Byung Kyu ^a   Hong, Soo Jin ^a   Kim, Yong Kook ^b   Moon, Jung Ae ^b   Kim, Ji Ha ^a   Chung, You Nam ^a   Wang, Kyu Chang ^a,c  

^a Seoul National University Hospital   (South Korea)

^b In2Gen Co Ltd   (South Korea)

^c Seoul National University Children's Hospital   (South Korea)

Author keywords

Cerebrospinal fluid; Electrophoresis, gel, two dimensional; Moyamoya disease; Protein binding; Receptors, retinoic acid; Spectrometry, mass, matrix assisted laser desorption ionization

Indexed keywords

CELLULAR RETINOIC ACID BINDING PROTEIN 1; RETINOIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG;

ANGIOGRAPHY; ARTICLE; BRAIN DISEASE; CEREBRAL PALSY; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DORSAL RHIZOTOMY; FEMALE; HUMAN; ISOELECTRIC POINT; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOYAMOYA DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL DENSITY; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; WESTERN BLOTTING;

BIOLOGICAL MARKERS; BLOTTING, WESTERN; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID PROTEINS; CHILD; CHILD, PRESCHOOL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; MALE; MOYAMOYA DISEASE; RECEPTORS, RETINOIC ACID; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0344304779     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000100159.43123.D7     Document Type: Article

References (35)

1. Hoshimaru M, Takahashi JA, Kikuchi H, et al. Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study. J Neurosurg. 1991;75:267-270.
2. Kono S, Oka K, Sueishi K. Histopathologic and morphometric studies of leptomeningeal vessels in moyamoya disease. Stroke. 1990;21:1044-1050.
3. Oka K, Yamashita M, Sadoshima S, et al. Cerebral haemorrhage in Moyamoya disease at autopsy. Virchows Arch A Pathol Anat Histol. 1981;392:247-261.
4. Ikezaki K, Kono S, Fukui M. Etiology of moyamoya disease: pathology, pathophysiology, and genetics. In: Ikezaki K, Loftus CM, eds. Moyamoya Disease. Rolling Meadows, Ill: American Association of Neurological Surgeons; 2001:55-64.
5. Malek AM, Connors S, Robertson RL, et al. Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders. Pediatr Neurosurg. 1997;27:182-189.
6. Suzui H, Hoshimaru M, Takahashi JA, et al. Immunohistochemical reactions for fibroblast growth factor receptor in arteries of patients with moyamoya disease. Neurosurgery. 1994;35:20-25.
7. Takahashi A, Sawamura Y, Houkin K, et al. The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor. Neurosci Lett. 1993;160:214-216.
8. Yoshimoto T, Houkin K, Takahashi A, et al. Angiogenic factors in moyamoya disease. Stroke. 1996;27:2160-2165.
9. Hojo M, Hoshimaru M, Miyamoto S, et al. Role of transforming growth factor-β1 in the pathogenesis of moyamoya disease. J Neurosurg. 1998;89:623-629.
10. Aoyagi M, Fukai N, Matsushima Y, et al. Kinetics of 125I-PDGF binding and down-regulation of PDGF receptor in arterial smooth muscle cells derived from patients with moyamoya disease. J Cell Physiol. 1993;154:281-288.
11. Aoyagi M, Fukai N, Sakamoto H, et al. Altered cellular responses to serum mitogens, including platelet-derived growth factor, in cultured smooth muscle cells derived from arteries of patients with moyamoya disease. J Cell Physiol. 1991;147:191-198.
12. Aoyagi M, Fukai N, Yamamoto M, et al. Early development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. Stroke. 1996;27:1750-1754.
13. Hojo M, Hoshimaru M, Miyamoto S, et al. A cerebrospinal fluid protein associated with moyamoya disease: report of three cases. Neurosurgery. 1999;45:170-174.
14. Jensen ON, Wilm M, Shevchenko A, et al. Sample preparation methods for mass spectrometric peptide mapping directly from 2-DE gels. Methods Mol Biol. 1999;112:513-530.
15. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 1975;250:4007-4021.
16. Pandey A, Mann M. Proteomics to study genes and genomes. Nature. 2000;405:837-846.
17. Berndt P, Hobohm U, Langen H. Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints. Electrophoresis. 1999;20:3521-3526.
18. Jensen ON, Mortensen P, Vorm O, et al. Automation of matrix-assisted laser desorption/ionization mass spectrometry using fuzzy logic feedback control. Anal Chem. 1997;69:1706-1714.
19. Suzuki J, Kodama N. Moyamoya disease: a review. Stroke. 1983;14:104-109.
20. Appel RD, Sanchez JC, Bairoch A, et al. SWISS-2DPAGE: a database of two-dimensional gel electrophoresis images. Electrophoresis. 1993;14:1232-1238.
21. Hoogland C, Sanchez JC, Tonella L, et al. Current status of the SWISS-2DPAGE database. Nucleic Acids Res. 1998;26:332-333.
22. Miano JM, Berk BC. Retinoids: versatile biological response modifiers of vascular smooth muscle phenotype. Circ Res. 2000;87:355-362.
23. Chen S, Gardner DG. Retinoic acid uses divergent mechanisms to activate or suppress mitogenesis in rat aortic smooth muscle cells. J Clin Invest. 1998;102:653-662.
24. Kato S, Sasaguri Y, Morimatsu M. Down-regulation in the production of matrix metalloproteinase 1 by human aortic intimal smooth muscle cells. Biochem Mol Biol Int. 1993;31:239-248.
25. Miano JM, Topouzis S, Majesky MW, et al. Retinoid receptor expression and all-trans retinoic acid-mediated growth inhibition in vascular smooth muscle cells. Circulation. 1996;93:1886-1895.
26. DeRose JJ Jr., Madigan J, Umana JP, et al. Retinoic acid suppresses intimal hyperplasia and prevents vessel remodeling following arterial injury. Cardiovasc Surg. 1999;7:633-639.
27. Miano JM, Kelly LA, Artacho CA, et al. All-trans-retinoic acid reduces neointimal formation and promotes favorable geometric remodeling of the rat carotid artery after balloon withdrawal injury. Circulation. 1998;98:1219-1227.
28. Neuville P, Yan Z, Gidlof A, et al. Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RARalpha-dependent signaling pathway. Arterioscler Thromb Vasc Biol. 1999;19:1430-1436.
29. Dong D, Ruuska SE, Levinthal DJ, et al. Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. J Biol Chem. 1999;274:23695-23698.
30. Astrom A, Pettersson U, Chambon P, et al. Retinoic acid induction of human cellular retinoic acid-binding protein-II gene transcription is mediated by retinoic acid receptor-retinoid X receptor heterodimers bound to one far upstream retinoic acid-responsive element with 5-base pair spacing. J Biol Chem. 1994;269:22334-22339.
31. Boylan JF, Gudas LJ. The level of CRABP-I expression influences the amounts and types of all-trans-retinoic acid metabolites in F9 teratocarcinoma stem cells. J Biol Chem. 1992;267:21486-21491.
32. Boylan JF, Gudas LJ. Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells. J Cell Biol. 1991;112:965-979.
33. Boyle BJ, Harris VK, Liaudet-Coopman ED, et al. Differential regulation of a fibroblast growth factor-binding protein by receptor-selective analogs of retinoic acid. Biochem Pharmacol. 2000;60:1677-1684.
34. Salbert G, Fanjul A, Piedrafita FJ, et al. Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity. Mol Endocrinol. 1993;7:1347-1356.
35. Kim SK, Wang KC, Kim IO, et al. Combined encephaloduroarteriosynangiosis and bifrontal encephalogaleo(periosteal)synangiosis in pediatric moyamoya disease. Neurosurgery, 2002;50:88-96.